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The nature of codon 57 in the HLA-DQB gene was recently reported as a potential marker of genetic susceptibility to 
insulin-dependent diabetes mellitus. When exploring the relevance of this marker by using genomic DNA amplification, 
we encountered ifficulties resulting from the coamplification of the homologous DX,Y region. A simple strategy is pro- 
posed to amplify the DQj3 region exclusively. It involves the preliminary digestion of genomic DNA with a restriction 
enzyme which cleaves DXjl specifically, leaving intact the DQB sequence. The amplified material is suitable for dot blot 
analysis and restriction enzyme digestion. This strategy is of general interest when homologous sequences impair the 
specificity of enzymatic DNA amplification. 
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1. INTRODUCTION 
In vitro enzymatic amplification of specific 
DNA sequences from a complex template, viz. 
human genomic DNA, by the polymerase chain 
reaction (PCR), has become a powerful tool for 
molecular diagnosis of genetic diseases, direct 
cloning and sequencing of fragments of specific in- 
terest [l-5]. This approach, however, is often 
hampered by sequence homologies between 
members of a given gene family. When the in- 
terfering sequence belongs to a pseudogene or to a 
gene whose expression is limited to a particular cell 
type, the general approach has been to use mRNA 
isolated from the appropriate tissue as the starting 
material. This mRNA is first copied into cDNA 
before one can proceed to the amplification step. 
Such a strategy weighs too heavily, in terms of time 
and material, to be applicable to a very large series. 
Using this latter approach, Todd et al. [6] have 
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explored the sequence polymorphism of the four 
major expressed HLA class II gene products, in 
relation with the genetic susceptibility to insulin- 
dependent diabetes mellitus (IDDM). They found 
that the structure of the DQ molecule, especially 
the nature of residue 57 in DQ,& polypeptide chain, 
is critical in specifying both disease susceptibility 
and resistance to IDDM. Very early diagnosis of 
susceptibility to IDDM may be crucial for the suc- 
cess of newly introduced preventive and curative 
approaches involving immunosuppressive drugs 
171. 
In this context, we have initiated studies to 
characterize the structural variations in the region 
of the HLA-DQP codon 57 on a large series of pa- 
tients and controls of multiple ethnic origin to ap- 
preciate its value as a marker for IDDM 
susceptibility and resistance. In setting up a tech- 
nique applicable to such a large series, using 
genomic DNA as template, we encountered dif- 
ficulties due to the coamplification of the 
homologous HLA-DXfl region. We have over- 
come this problem by devising a simple strategy 
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which should be of general use in any similar situa- 
tion involving homologous sequences. 
2. MATERIALS AND METHODS 
Human genomic DNA was prepared by any of the three 
following procedures: phenol-chloroform extraction [S], 
guanidinium chloride method [9] or protein salting out [lo]. 
Supernatant of 2004 of boiled human whole blood was also 
satisfactorily used as a source of DNA template. HLA-DQP ex- 
on 2 was amplified using the primers reported by Todd et al. 
[6]. Relevant synthetic oligonucleotides used as primers and 
probes [6] were prepared on a Pharmacia gene assembler by the 
,&cyanoethyl phosphoramidite method and purified by electro- 
phoresis on 20% polyacrylamide gels. PCR was performed 
manually using TuqI polymerase from New England Biolabs or 
from Cetus Corporation according to the instructions of the 
first manufacturer. All restriction enzyme digestions were car- 
ried out according to the manufacturer’s advice (New England 
Biolabs). Analytical minipolyacrylamide gels were run in a Pro- 
tean II cell (Biorad). 
3. RESULTS AND DISCUSSION 
When lpg of genomic DNA was submitted to 30 
cycles of PCR and the product analyzed by electro- 
phoresis on agarose gel, a single major amplifica- 
tion product of 241 bp size was observed (fig.lB), 
which hybridized with a HLA-DQ,& cDNA probe 
(fig.lA). However, when this product was submit- 
ted to digestion with SmaI, a restriction enzyme 
which should cleave the amplified DQ@ sequence, 
a smaller 199 bp fragment was clearly visible, but 
the 241 bp fragment, although diminished in inten- 
sity, remained consistently present despite exten- 
sive digestion (fig.2A, lane 1). Given the fact that 
no SmaI recognition site is present in the 
homologous region of DX,8 [l I], coamplification 
of DXfl together with DQ@ is a likely explanation 
for the persistence of the 241 bp fragment upon 
digestion with this enzyme. This hypothesis was 
tested by digestion with the restriction enzyme 
TaqI which should cleave both sequences. As 
shown in fig.2A (lane 3), the 241 bp fragment then 
totally disappeared in favor of four fragments of 
smaller sizes, all corresponding to the known 
restriction map of the amplified DXp and DQP 
regions. Therefore, these two regions indeed 
coamplified .
We have taken advantage of these restriction 
recognition sequence differences between DX,f3 
and DQfl regions to devise a strategy involving 
selective cleavage of DX,8 prior to the amplifica- 
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Fig. 1. Amplification of the HLA-DQB region. HLA-DQj3 exon 
2 was enzymatically amplified using as template 1 ,ug of native 
DNA from two independent individuals (lanes 1 and 2). (A) 
Hybridization of the amplified material with a “P-1abelled 
HLA-DQ/3 cDNA probe (kindly provided by Dr P.A. Peterson 
[12]). DNA was capillary blotted from gel B to a nylon mem- 
brane (Gene Screen Plus, New England Nuclear). (B) Analysis 
of a 5% aliquot of the amplified material by electrophoresis on 
a 2.2% agarose gel (lane 3 = size markers). The gel was stained 
with ethidium bromide. 
tion step. Disruption of theeDNA covalent struc- 
ture between the two primers should naturally 
abolish the exponential kinetics of the amplifica- 
tion reaction of DX,8. The enzyme BstEII was 
chosen for its capacity to cleave within DXp, leav- 
ing intact the target DQfl sequence. Digestion of 
the DNA template with BsrEII resulted in a consis- 
tent decrease (around 50%) in the intensity of the 
amplified fragment in agarose gel when compared 
to that of an undigested sample (fig.2B). However, 
doubling the amount of template restored the 
original intensity of the amplified material, sug- 
gesting that the target DQ,8 sequence was indeed 
the limiting factor and that the intensity reduction 
was due to the absence of amplification of DX,8 
and not to nuclease contamination. In order to 
verify if the amplified sequences were now strictly 
restricted to the DQ,f3 target, they were digested 
with SmaI and TaqI restriction enzymes, respec- 
tively. As could be visualized by polyacrylamide 
gel electrophoresis, SmaI treatment now resulted 
in the complete digestion of the 241 bp fragment 
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Fig.2. Effect of BstEII digestion of the DNA template. (A) 
Restriction analysis of the amplified HLA regions. Genomic 
DNA used as the amplification template was either native (lanes 
1 and 3) or predigested with BstEII (lanes 2 and 4). A 10% ali- 
quot of the amplified product was submitted to digestion with 
SmaI (lanes 1 and 2) or TuqI (lanes 3 and 4). Digests were size- 
fractionated by electrophoresis on a 8% polyacrylamide gel and 
stained with ethidium bromide. The upper part of the figure in- 
dicates SmaI and 7’uqI sites in the DQfl and DX@ homologous 
regions as well as the sizes of the expected fragments. (B) 
Analysis of the amplified material from three different in- 
dividuals. The amplification template was either native DNA 
(lanes l-3) or the same DNA samples predigested with BsfEII 
(lanes 4-6). The 2.0% agarose gel was stained with ethidium 
bromide. 
(fig.2A, lane 2) and the four-band pattern 
previously observed with TaqI was reduced to two 
bands (fig.2A, lane 4). These data are consistent 
with the complete absence of amplification of the 
DX/3 region and the selective amplification of 
DQP. 
From the sequence data, two other enzymes, 
HaeII and Bali, should also cleave differentially 
the DQP and DX,8 regions and therefore could 
potentially be used for preamplification digestion. 
Actually, Bali, an expensive enzyme, gave ir- 
reproducible digestion efficiency on the whole, 
whereas HaeII produced results with wide interin- 
dividual variations due, we believe, to sequence 
polymorphism. This was not the case with BstEII 
predigestion as has been experienced by us with 
several samples of DNA from different ethnic 
groups. 
Restriction enzymes have already been used to 
characterize PCR products [ 1,131. However, such 
an analysis is obviously complicated if two, or 
more, homologous regions are coamplified, in par- 
ticular when, as here, those sequences are naturally 
polymorphic. In any such situation, we propose to 
cut the DNA before amplification in order to 
specifically generate a unique sequence. General- 
ization of this strategy is exemplified by the fact 
that conversely, we were able to amplify selectively 
DXfi by predigesting the template DNA with 
SmaI. We have also tested this approach suc- 
cessfully on an other duplicated gene family, viz. 
the highly homologous human y-globin genes. 
Allele specific oligonucleotides have been used 
by Todd et al. [6] to detect the sequence variations 
at the position of DQp codon 57 by dot blot 
analysis of the PCR product of genomic DNA. At 
present, because the relation between the nature of 
codon 57 and IDDM is not absolute and still con- 
troversial [14], such a targeted approach is very 
much restricted. It seems therefore important to 
look for other allelic variations in this polymorphic 
region through population studies. This is con- 
ceivable either by restriction enzyme analysis or by 
direct sequencing of the amplified product. Both 
approaches necessitate that the amplified material 
be unique for the DQP locus. This is achieved by 
the strategy we propose, which by bypassing the 
mRNA and cDNA preparations has two further 
advantages, (i) it requires only small quantities of 
starting material, even obtainable by non-invasive 
methods [13], and (ii) potential reverse 
transcriptase-induced errors are avoided. 
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